Compare EXTR & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXTR | PRGO |
|---|---|---|
| Founded | 1996 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 1999 | 2013 |
| Metric | EXTR | PRGO |
|---|---|---|
| Price | $15.51 | $10.57 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $21.20 | $19.33 |
| AVG Volume (30 Days) | 1.1M | ★ 3.7M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 10.95% |
| EPS Growth | ★ 90.91 | N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $1,140,067,000.00 | $800,000.00 |
| Revenue This Year | $13.15 | N/A |
| Revenue Next Year | $7.52 | $1.02 |
| P/E Ratio | $154.50 | ★ N/A |
| Revenue Growth | ★ 2.05 | N/A |
| 52 Week Low | $10.61 | $9.23 |
| 52 Week High | $22.89 | $28.44 |
| Indicator | EXTR | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 60.75 | 47.08 |
| Support Level | $13.97 | $9.24 |
| Resistance Level | $15.74 | $15.08 |
| Average True Range (ATR) | 0.43 | 0.53 |
| MACD | 0.05 | 0.30 |
| Stochastic Oscillator | 83.62 | 64.25 |
Extreme Networks Inc provides AI-powered cloud networking, focused on delivering simple and secure solutions that help businesses address challenges and enable connections among devices, applications, and users. The group designs, develops, and manufactures wired, wireless, and software-defined wide area network (SD-WAN) infrastructure equipment. It has one reportable segment, the development, marketing, and sale of network infrastructure equipment and related software. The Company operates in three geographical areas: Americas, EMEA, and APAC.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.